Search
Mesa Laboratories Inc
MLABAdd to Watchlist
105.540USD
+1.150+1.10%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
583.10MMarket Cap
160.59P/E TTM
More Details of Mesa Laboratories Inc Company
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Mesa Laboratories Inc Info
Ticker SymbolMLAB
Company nameMesa Laboratories Inc
IPO dateFeb 29, 1984
CEOOwens (Gary M)
Number of employees730
Security typeOrdinary Share
Fiscal year-endFeb 29
Address12100 W 6th Ave
CityLAKEWOOD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code80228
Phone13039878000
Websitehttps://mesalabs.com
Ticker SymbolMLAB
IPO dateFeb 29, 1984
CEOOwens (Gary M)
Company Executives of Mesa Laboratories Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+7.80%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.85%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
46.44K
+10.21%
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+7.80%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.85%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
46.44K
+10.21%
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
FAQs
Who are the top five shareholders of Mesa Laboratories Inc?
The top five shareholders of Mesa Laboratories Inc are: Mr. Gary M. Owens
How many institutions hold shares of Mesa Laboratories Inc (MLAB)?
As of 2026Q1, 397 institutions hold shares of Mesa Laboratories Inc, with a combined market value of approximately 5.55M, accounting for 100.49% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -254194.00.
What is the biggest source of revenue for Mesa Laboratories Inc?
In 2026Q1, the Discrete Revenues- Consumables business generated the highest revenue for Mesa Laboratories Inc, amounting to 36.73M and accounting for 56.40% of total revenue.